Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
2011 StandoutScience
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor
2007 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
The Hypoxia-Inducible Factor 2α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo
2007 StandoutNobel
Optical coherence tomography angiography
2017 Standout
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations
2007 StandoutNobel
Optical Coherence Tomography–Defined Changes Preceding the Development of Drusen-Associated Atrophy in Age-Related Macular Degeneration
2014
En Face Optical Coherence Tomography Imaging for the Detection of Nascent Geographic Atrophy
2016
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
2016
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect
1995
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel–Lindau disease
2004
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
2001
Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials
2016
Recent Insights into the Molecular Pathogenesis of Pheochromocytoma and Paraganglioma
2006 StandoutNobel
Von Hippel‐Lindau gene alterations in sporadic benign and malignant pheochromocytomas
2003
Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration
2016
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Phaeochromocytoma
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Hereditary paraganglioma targets diverse paraganglia: Table 1
2002
Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
2002
Retinopathy of prematurity
2013 Standout
Clinical Characteristics of Ocular Angiomatosis in von Hippel-Lindau Disease and Correlation With Germline Mutation
1999
Von Hippel‐Lindau disease
2003
Radiosurgery for hemangioblastoma: Results of a multiinstitutional experience
1996
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
2014
Treatment of retinal capillary hemangioma
2002
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Age-related macular degeneration
2012 Standout
Pheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
2002
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
1999 StandoutNobel
Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy
2003
Clinical features of polymyalgia rheumatica and giant cell arteritis
2012
Combined Confocal Scanning Laser Ophthalmoscopy and Spectral-Domain Optical Coherence Tomography Imaging of Reticular Drusen Associated with Age-Related Macular Degeneration
2010
von Hippel-Lindau disease
2003 Standout
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor
2004 StandoutNobel
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Clinical Application of Multicolor Imaging Technology
2016
Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416
2002
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
2006 StandoutNobel
Modifiers of risk of hereditary breast and ovarian cancer
2002
Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes
2016
Age-related macular degeneration
2018 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Investigating the choriocapillaris and choroidal vasculature with new optical coherence tomography technologies
2015
Germline mutations in thevhl gene in patients presenting with phaeochromocytomas
1998
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins
2009
Distinct Clinical Features of Paraganglioma Syndromes Associated With <EMPH TYPE="ITAL">SDHB</EMPH> and <EMPH TYPE="ITAL">SDHD</EMPH> Gene Mutations
2004
SUBRETINAL DRUSENOID DEPOSITS IN NON-NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
2012
Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel–Lindau Disease and Multiple Endocrine Neoplasia Type 2
1999
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
2003
A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration
2016
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Von Hippel‐Lindau Syndrome
1995
Vascular Endothelial Growth Factor Expression in the Retinal Pigment Epithelium Is Essential for Choriocapillaris Development and Visual Function
2005
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in thevhlTumor Suppressor Gene or theretProtooncogene1
1997
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas1
2000
Retinal angiomatous proliferation
2017
Stem cell based therapies for age-related macular degeneration: The promises and the challenges
2015
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
2000
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina
2016
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
2016
Diagnosis of Pheochromocytoma
1988
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
1995 StandoutScienceNobel
Regulation of Dynamic Behavior of Retinal Microglia by CX3CR1 Signaling
2009
Quantum indistinguishability by path identity and with undetected photons
2022 StandoutNobel
PROLINE HYDROXYLATION AND GENE EXPRESSION
2005 StandoutNobel
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
1994
Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions
2017
Pheochromocytoma
2002
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
1999 StandoutScienceNobel
Pheochromocytoma: State-of-the-Art and Future Prospects
2003
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema
2012
Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
2002
Optical Coherence Tomography Angiography in Dry Age-Related Macular Degeneration
2017
Adrenal-sparing surgery for phaeochromocytoma
1999
Phaeochromocytoma with Normal Urinary Catecholamines: The Potential Value of Urinary Free Metadrenalines
2002
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
1995
Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2
1998 StandoutNobel
Duodenal Somatostatinoma and Erythrocytosis in a Patient with Von Hippel-Lindau Disease Type 2A.
2001
Consequences of Direct Genetic Testing for Germline Mutations in the Clinical Management of Families With Multiple Endocrine Neoplasia, Type II
1995
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
1998
IMPROVING THE AGE-RELATED MACULAR DEGENERATION CONSTRUCT
2017
Retinal Pigment Epithelial Detachments in Age-Related Macular Degeneration: Classification and Therapeutic Options
2011
Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
2000
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
CLINICAL AND GENETIC CHARACTERIZATION OF PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA
1999
Pheochromocytomas and Paragangliomas in von Hippel–Lindau Disease
2002
Thyroid carcinoma
2003 Standout
The Molecular Basis of Von Hippel-Lindau Disease
1997 StandoutNobel
Works of Nicole Eter being referenced
Retinal Vascular Hamartoma in von Hippel-Lindau Disease
1995
Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
2008
Human RPE Stem Cells Grown into Polarized RPE Monolayers on a Polyester Matrix Are Maintained after Grafting into Rabbit Subretinal Space
2014
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study
2008
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
1993
Retinal Pigment Epithelium Tears: Risk Factors, Mechanism and Therapeutic Monitoring
2015
VEGF-Production by CCR2-Dependent Macrophages Contributes to Laser-Induced Choroidal Neovascularization
2014
Localized Reticular Pseudodrusen and Their Topographic Relation to Choroidal Watershed Zones and Changes in Choroidal Volumes
2013
Impact of eye-tracking technology on OCT-angiography imaging quality in age-related macular degeneration
2017
Multifocal Electroretinography in Eyes with Reticular Pseudodrusen
2012
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high‐resolution, spectral‐domain optical coherence tomography
2009
Exploring choriocapillaris under reticular pseudodrusen using OCT-Angiography
2016
Assessment of the cranial involvement pattern of giant cell arteritis with 3t magnetic resonance imaging
2005
Characterisation of reticular pseudodrusen and their central target aspect in multi-spectral, confocal scanning laser ophthalmoscopy
2013
In Vivo Visualization of Dendritic Cells, Macrophages, and Microglial Cells Responding to Laser-Induced Damage in the Fundus of the Eye
2008
Tracking Progression with Spectral-Domain Optical Coherence Tomography in Geographic Atrophy Caused by Age-Related Macular Degeneration
2010
Subretinal Delivery of Ultrathin Rigid-Elastic Cell Carriers Using a Metallic Shooter Instrument and Biodegradable Hydrogel Encapsulation
2011
Prevention of serious ophthalmic and cerebral complications in temporal arteritis?
2000
Diagnostic Value of High-Resolution MR Imaging in Giant Cell Arteritis
2007
Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease.
2000